and maximize the efficiency of AI operations. Founded in 2024, Claros is backed by Red Cell Partners, General Catalyst, VIPC, and others. Visit us at claros.tech and follow us on Linkedin.

Rubius Therapeutics is biologically engineering red blood cells to provide a new class ... The company’s highly experienced technical operations team is achieving over 90% lot success rate ...